Cubist Pharmaceuticals has received the US Food and Drug Administration (FDA) fast track status for its late-stage antibiotic candidate ceftolozane/tazobactam in the previously granted Qualified Infectious Disease Product (QIDP) ...
Tags: Cubist, Fast Track Status
Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for ...
Tags: Curis, Erivedge Anti-Cancer Drug
Cornerstone Therapeutics has signed an agreement to acquire exclusive US marketing rights to Pertzye (pancrelipase) from Digestive Care (DCI). Pertzye, the pancreatic enzyme product, is indicated for the treatment of exocrine pancreatic ...
Tags: Cornerstone, Digestive Care
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England. The new venture, Redx Anti-Infectives, will ...
Tags: Redx Pharma, Medicine
Finnish drug maker Biohit Oyj will reportedly launch patent drug Acetuim that could control blastomogen acetaldehyde, which is oriented to the Chinese market, revealed the CEO of the company Semi Korpela. Biohit Oyj is currently ...
Tags: Stomach Medicine, Medicine
San Carlos, California, United States of America (Free-Press-Release.com) May 7, 2013 -- Rosa & Co. LLC today announced that Dr. Michael A. Eldon, Principal Scientific Fellow, VP, Clinical Pharmacology, Nektar Therapeutics, will present a ...
Nimbus Discovery, a US-based biotechnology company, has entered into a co-development agreement with Shire aiming at small molecule treatments for lysosomal storage disorders (LSDs), which are considered as the rare genetic diseases. The ...
The US Food and Drug Administration (FDA) has warned the people that the anti-seizure drug, Potiga, developed by Valeant Pharmaceuticals and co-marketed with GlaxoSmithKline, may cause eye and skin problems. FDA warned that Potiga may ...
Tags: Anti-Seizure Drug Potiga, Medicine
Abbott has received CE Mark for its Architect clinical chemistry Hemoglobin A1c (HbA1c) test, which may assist physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes. The HbA1c ...
NEC Display Solutions of America has received the Food and Drug Administration 510(k) market clearance of the 21-inch MultiSync MD211C2 and MD211C3 medical-grade monitors, which will display digital images for diagnosis by trained ...
Tags: NEC Display Solutions, Medicine
FOR IMMEDIATE RELEASE San Carlos, California, United States of America (Free-Press-Release.com) May 9, 2013 -- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that ...
Tags: Construction, Decoration
Roche Group recently declared cooperation with Ascletis in joint developing Danoprevir that is used for curing Hepatitis C, marking beginning of cooperative research and development, production and sale of new drugs in China with local ...
Plans announced by the Coalition to review the Road Safety Remuneration Tribunal in the event of winning September’s Federal election ignore all of the evidence collected over twenty years showing a direct relationship between pay and ...
Tags: Coalition, Coalition IR Policy
The US Food and Drug Administration (FDA) has approved Biolase's WaterLase iPlus all-tissue laser for soft-tissue procedures in orthopedic and podiatric surgery as a surgical instrument. The iPlus has been cleared for incision, excision, ...
Tags: Podiatric Surgeries, Medicine
BSD Medical has received an initial purchase order from its exclusive Taiwan distributor Linden Bioscence to supply four BSD-2000 Hyperthermia Systems (BSD-2000). Developed and patented by BSD Medical, the BSD-2000 delivers localized ...
Tags: BSD Medical, Hyperthermia Systems